## TP53 and Tumor Suppression in Esophageal Cancer ### Role of TP53 Gene **Key Point:** TP53 encodes the p53 protein, a critical tumor suppressor often called the "guardian of the genome." Loss of both alleles (biallelic inactivation) is a hallmark of many human cancers, including esophageal squamous cell carcinoma. ### Mechanism of Loss in Carcinogenesis 1. **Normal function:** p53 activates cell cycle arrest (via p21), DNA repair mechanisms, and apoptosis in response to cellular stress. 2. **Loss of wild-type allele:** When both copies are inactivated (as in this case), the cell loses the ability to: - Halt proliferation for DNA repair - Trigger programmed cell death in response to oncogenic signals - Maintain genomic stability ### Classification in Carcinogenesis **High-Yield:** TP53 is a **tumor suppressor** (recessive at the cellular level), not a proto-oncogene. Loss-of-function mutations drive cancer; gain-of-function mutations do not apply here. ### Clinical Pearl TP53 mutations are found in ~90% of esophageal squamous cell carcinomas in high-risk populations (tobacco and alcohol exposure), making it one of the most frequently altered genes in this malignancy [cite:Robbins 10e Ch 7]. ### Why This Matters in Pathogenesis **Mnemonic: GASP** — **G**enome instability, **A**poptosis evasion, **S**talled cell cycle, **P**53 loss. Without functional p53, accumulated mutations in other oncogenes (e.g., KRAS, MYC) proceed unchecked, driving multi-step carcinogenesis. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.